BCYC

Bicycle Therapeutics
BCYC

Overview Fund Activity

101 hedge funds and large institutions have $651M invested in Bicycle Therapeutics in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 7 closing their positions.

Holders
101
Holders Change
+16
Holders Change %
+18.82%
% of All Funds
1.61%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
24
Increased
36
Reduced
23
Closed
7
Calls
$2.04M
Puts
$3.84M
Net Calls
-$1.8M
Net Calls Change
+$3.32M

Top Buyers

1
PBA
1
Paradigm Biocapital Advisors
New York
$73.2M
2
B
2
Braidwell
Connecticut
$25.9M
3
SCM
3
Suvretta Capital Management
New York
$20.3M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$26.1M
5
RCM
5
RA Capital Management
Massachusetts
$16.1M

Top Sellers

1
LGM
1
Logos Global Management
California
$0
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$18.3M
3
IC
3
Ikarian Capital
Texas
$0
4
SCM
4
Sio Capital Management
New York
$16M
5
ECM
5
ExodusPoint Capital Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
101
Wells Fargo
California
$241 +$241 +12 New
LGM
102
Logos Global Management
California
– -$13.3M -520,000 Closed
IC
103
Ikarian Capital
Texas
– -$5.18M -203,037 Closed
ECM
104
ExodusPoint Capital Management
New York
– -$2.86M -111,973 Closed
BFM
105
Boothbay Fund Management
New York
– -$1.08M -42,133 Closed
Goldman Sachs
106
Goldman Sachs
New York
– -$465K -18,215 Closed
Marshall Wace
107
Marshall Wace
United Kingdom
– -$237K -9,271 Closed
PCM
108
Prelude Capital Management
New York
– -$231K -9,061 Closed
1 2 3 4
5